Last updated: 2026-10-16 17:31:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Vericel Corporation (VCEL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $40,14, with a market capitalization of $2,06B and a P/E ratio of 86,72. Over the past 52 weeks, its price has ranged from $28,95 to $49,32. This page covers its latest market performance, valuation, price trends and company information.
$2,06B | |
$41,07 | |
$68,94 | |
$1,69 | |
$41,02 | |
173,36K | |
511,23K | |
86,72 | |
$49,32 | |
$28,95 | |
-- | |
-- |
Vericel Corporation (VCEL) is currently trading at $40,14 as of 2026-10-16 17:29:00, down 2,15% ($0,88) from the previous close of $41,02
During today's regular trading session, VCEL has traded between $1,69 and $68,94, with a trading volume of 173,36K shares. The current price is near the middle of today's range.
Over the past seven days, Vericel Corporation (VCEL) moved from $40,74 to $40,14, representing a decline of 1,47% ($0,60).
The stock traded between $35,72 and $41,60 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.
The average daily volume was 547,63 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 54,9%
VCEL is currently trading at $40,14, placing it 54,9% of the way from its 52-week low of $28,95 to its 52-week high of $49,32. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 398 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Vericel Corporation (VCEL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.